These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33851448)

  • 61. Lower glycemic indices and lipid profile among type 2 diabetes mellitus patients who received novel dose of Silybum marianum (L.) Gaertn. (silymarin) extract supplement: A Triple-blinded randomized controlled clinical trial.
    Ebrahimpour-Koujan S; Gargari BP; Mobasseri M; Valizadeh H; Asghari-Jafarabadi M
    Phytomedicine; 2018 May; 44():39-44. PubMed ID: 29895491
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nutraceutical Effects on Glucose and Lipid Metabolism in Patients with Impaired Fasting Glucose: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial on a Combined Product.
    Cicero AFG; Fogacci F; Morbini M; Colletti A; Bove M; Veronesi M; Giovannini M; Borghi C
    High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):283-288. PubMed ID: 28537012
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of hesperidin supplementation on metabolic profiles in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial.
    Yari Z; Movahedian M; Imani H; Alavian SM; Hedayati M; Hekmatdoost A
    Eur J Nutr; 2020 Sep; 59(6):2569-2577. PubMed ID: 31844967
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effects of flaxseed supplementation on metabolic syndrome parameters, insulin resistance and inflammation in ulcerative colitis patients: An open-labeled randomized controlled trial.
    Morshedzadeh N; Rahimlou M; Shahrokh S; Karimi S; Mirmiran P; Zali MR
    Phytother Res; 2021 Jul; 35(7):3781-3791. PubMed ID: 33856729
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha.
    Derosa G; Cicero AF; D'Angelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo SA; Ferrari I; Gravina A; Fogari R
    Hypertens Res; 2006 Nov; 29(11):849-56. PubMed ID: 17345784
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Curcumin Nanomicelle Improves Lipid Profile, Stress Oxidative Factors and Inflammatory Markers in Patients Undergoing Coronary Elective Angioplasty; A Randomized Clinical Trial.
    Helli B; Gerami H; Kavianpour M; Heybar H; Hosseini SK; Haghighian HK
    Endocr Metab Immune Disord Drug Targets; 2021; 21(11):2090-2098. PubMed ID: 33397249
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial.
    Panahi Y; Khalili N; Sahebi E; Namazi S; Reiner Ž; Majeed M; Sahebkar A
    Complement Ther Med; 2017 Aug; 33():1-5. PubMed ID: 28735818
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of carnosine supplementation on lipid profile, fasting blood glucose, HbA1C and insulin resistance: A systematic review and meta-analysis of long-term randomized controlled trials.
    Peng W; Mao P; Liu L; Chen K; Zhong Y; Xia W; Guo Q; Tan SC; Rahmani J; Kord Varkaneh H; He P
    Complement Ther Med; 2020 Jan; 48():102241. PubMed ID: 31987255
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome.
    Simons L; Tonkon M; Masana L; Maccubbin D; Shah A; Lee M; Gumbiner B
    Curr Med Res Opin; 2004 Sep; 20(9):1437-45. PubMed ID: 15383192
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of oral magnesium supplement on cardiometabolic markers in people with prediabetes: a double blind randomized controlled clinical trial.
    Salehidoost R; Taghipour Boroujeni G; Feizi A; Aminorroaya A; Amini M
    Sci Rep; 2022 Oct; 12(1):18209. PubMed ID: 36307427
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
    Daneshi-Maskooni M; Keshavarz SA; Qorbani M; Mansouri S; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    BMC Complement Altern Med; 2019 Mar; 19(1):59. PubMed ID: 30871514
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lipid-lowering effects of curcumin in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled trial.
    Yang YS; Su YF; Yang HW; Lee YH; Chou JI; Ueng KC
    Phytother Res; 2014 Dec; 28(12):1770-7. PubMed ID: 25131839
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: A randomized, double-blind, placebo-controlled trial.
    Karamali M; Dadkhah F; Sadrkhanlou M; Jamilian M; Ahmadi S; Tajabadi-Ebrahimi M; Jafari P; Asemi Z
    Diabetes Metab; 2016 Sep; 42(4):234-41. PubMed ID: 27209439
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effects of butyrate supplementation on glycemic control, lipid profile, blood pressure, nitric oxide level and glutathione peroxidase activity in type 2 diabetic patients: A randomized triple -blind, placebo-controlled trial.
    Khosravi Z; Hadi A; Tutunchi H; Asghari-Jafarabadi M; Naeinie F; Roshanravan N; Ostadrahimi A; Fadel A
    Clin Nutr ESPEN; 2022 Jun; 49():79-85. PubMed ID: 35623879
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Magnesium-zinc-calcium-vitamin D co-supplementation improves glycemic control and markers of cardiometabolic risk in gestational diabetes: a randomized, double-blind, placebo-controlled trial.
    Karamali M; Bahramimoghadam S; Sharifzadeh F; Asemi Z
    Appl Physiol Nutr Metab; 2018 Jun; 43(6):565-570. PubMed ID: 29316405
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of pomegranate extract on anthropometric indices, serum lipids, glycemic indicators, and blood pressure in patients with nonalcoholic fatty liver disease: A randomized double-blind clinical trial.
    Goodarzi R; Jafarirad S; Mohammadtaghvaei N; Dastoorpoor M; Alavinejad P
    Phytother Res; 2021 Oct; 35(10):5871-5882. PubMed ID: 34498307
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of curcumin and zinc co-supplementation on glycemic parameters in overweight or obese prediabetic subjects: A phase 2 randomized, placebo-controlled trial with a multi-arm, parallel-group design.
    Karandish M; Mozaffari-Khosravi H; Mohammadi SM; Cheraghian B; Azhdari M
    Phytother Res; 2021 Aug; 35(8):4377-4387. PubMed ID: 33893671
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
    Ebrahimi-Mameghani M; Sadeghi Z; Abbasalizad Farhangi M; Vaghef-Mehrabany E; Aliashrafi S
    Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Effect of Magnesium and Vitamin E Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Sabzevar NK; Asemi Z
    Horm Metab Res; 2019 Feb; 51(2):100-105. PubMed ID: 30286483
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy of curcumin plus piperine co-supplementation in moderate-to-high hepatic steatosis: A double-blind, randomized, placebo-controlled clinical trial.
    Sharifi S; Bagherniya M; Khoram Z; Ebrahimi Varzaneh A; Atkin SL; Jamialahmadi T; Sahebkar A; Askari G
    Phytother Res; 2023 Jun; 37(6):2217-2229. PubMed ID: 36799355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.